The store will not work correctly when cookies are disabled.
4-(5-(2-chlorophenoxy)-1H-indazol-1-yl)-N-methylthiophene-2-carboxamide
ID: ALA4864514
PubChem CID: 156155391
Max Phase: Preclinical
Molecular Formula: C19H14ClN3O2S
Molecular Weight: 383.86
Molecule Type: Unknown
Associated Items:
Names and Identifiers
Canonical SMILES: CNC(=O)c1cc(-n2ncc3cc(Oc4ccccc4Cl)ccc32)cs1
Standard InChI: InChI=1S/C19H14ClN3O2S/c1-21-19(24)18-9-13(11-26-18)23-16-7-6-14(8-12(16)10-22-23)25-17-5-3-2-4-15(17)20/h2-11H,1H3,(H,21,24)
Standard InChI Key: JAPSMYSZFOTZPZ-UHFFFAOYSA-N
Molfile:
RDKit 2D
26 29 0 0 0 0 0 0 0 0999 V2000
28.4449 -23.9833 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.1567 -23.5706 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.7330 -23.5706 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
28.4449 -24.8046 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
29.9095 -23.9081 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
30.4604 -23.2966 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.0477 -22.5848 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.2443 -22.7548 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.3800 -21.8341 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
30.5190 -20.5191 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.9682 -21.1265 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
31.2624 -20.8504 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.1785 -21.6701 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.8459 -22.1528 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.5978 -21.8129 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.6781 -20.9897 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.0097 -20.5147 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.4263 -20.6519 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
33.5058 -19.8345 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.2537 -19.4968 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.3335 -18.6801 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.6643 -18.2038 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.9175 -18.5457 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.8372 -19.3614 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.9213 -19.9781 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
27.7330 -22.7493 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
1 3 1 0
1 4 2 0
2 5 1 0
5 6 1 0
6 7 2 0
7 8 1 0
8 2 2 0
7 9 1 0
9 13 1 0
12 10 1 0
10 11 2 0
11 9 1 0
12 13 2 0
13 14 1 0
14 15 2 0
15 16 1 0
16 17 2 0
17 12 1 0
16 18 1 0
18 19 1 0
19 20 2 0
20 21 1 0
21 22 2 0
22 23 1 0
23 24 2 0
24 19 1 0
20 25 1 0
3 26 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 383.86 | Molecular Weight (Monoisotopic): 383.0495 | AlogP: 4.89 | #Rotatable Bonds: 4 |
Polar Surface Area: 56.15 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 0.77 | CX LogP: 4.17 | CX LogD: 4.17 |
Aromatic Rings: 4 | Heavy Atoms: 26 | QED Weighted: 0.55 | Np Likeness Score: -1.56 |
References
1. Feng Y, Park H, Ryu JC, Yoon SO.. (2021) N-Aromatic-Substituted Indazole Derivatives as Brain-Penetrant and Orally Bioavailable JNK3 Inhibitors., 12 (10.0): [PMID:34676036] [10.1021/acsmedchemlett.1c00334] |